Novo Nordisk
NVO
#78
Rank
โ‚ฌ182.65 B
Marketcap
41,11ย โ‚ฌ
Share price
-0.27%
Change (1 day)
-60.16%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚ฌ18.71 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚ฌ47.21 Billion. In 2024 the company made an earning of โ‚ฌ16.25 Billion, an increase over its 2023 earnings that were of โ‚ฌ13.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ18.71 B15.12%
2024 โ‚ฌ16.25 B22.84%
2023 โ‚ฌ13.23 B57.81%
2022 โ‚ฌ8.38 B5.24%
2021 โ‚ฌ7.96 B12.38%
2020 โ‚ฌ7.09 B13.11%
2019 โ‚ฌ6.26 B-3.45%
2018 โ‚ฌ6.49 B1.88%
2017 โ‚ฌ6.37 B4.3%
2016 โ‚ฌ6.10 B10.32%
2015 โ‚ฌ5.53 B7.47%
2014 โ‚ฌ5.15 B3.4%
2013 โ‚ฌ4.98 B19.09%
2012 โ‚ฌ4.18 B15.58%
2011 โ‚ฌ3.62 B16.58%
2010 โ‚ฌ3.10 B25.66%
2009 โ‚ฌ2.47 B10.68%
2008 โ‚ฌ2.23 B55.82%
2007 โ‚ฌ1.43 B7.02%
2006 โ‚ฌ1.33 B19.05%
2005 โ‚ฌ1.12 B10.55%
2004 โ‚ฌ1.01 B
2002 โ‚ฌ0.69 B-14.39%
2001 โ‚ฌ0.81 B-52.82%
2000 โ‚ฌ1.72 B250%
1999 โ‚ฌ0.49 B31.21%
1998 โ‚ฌ0.37 B34.31%
1997 โ‚ฌ0.28 B11.46%
1996 โ‚ฌ0.25 B9.03%
1995 โ‚ฌ0.23 B-3.15%
1994 โ‚ฌ0.23 B-0.67%
1993 โ‚ฌ0.23 B45.38%
1992 โ‚ฌ0.16 B-13.81%
1991 โ‚ฌ0.19 B37.12%
1990 โ‚ฌ0.13 B-0.79%
1989 โ‚ฌ0.14 B26.2%
1988 โ‚ฌ0.11 B24.97%
1987 โ‚ฌ89.19 M-0.9%
1986 โ‚ฌ90.01 M-7.78%
1985 โ‚ฌ97.6 M24.87%
1984 โ‚ฌ78.16 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ10.17 B-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ19.32 B 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.89 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.81 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France